Here's a look at the top stocks that may hog the limelight in today's session:

"The company has received final approval from the USFDA to manufacture abacavir sulfate and lamivudine tablets, 600 mg/ 300 mg."

The company had earlier received approval from the United States Food and Drug Administration for Abacavir and Lamivudine tablets 600 mg/30...

Lupin launched the generic version of ViiV Healthcare's Trizivir tablets in the US market with 180-days of marketing exclusivity.

The company's product is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection, it added.

Aurobindo Pharma said it has received US health regulator's final approval to market Abacavir Tablets, used in the treatment of HIV in the ...

Drug firm Stride Arcolab has received a tentative approval from US health regulator Food and Drug Administration (FDA) for generic drug aba...

Aurobindo Pharma on Friday said it has received approval from the US drug regulator for manufacturing and marketing two drugs - Cyclobenzap...

Pharma major Ranbaxy said the World Health Organisation has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification...

In a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...